Quick Answer
Denali Therapeutics Inc. reported Total Assets of $1.14 billion for fiscal year 2025.
Denali Therapeutics Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $1.14B | -16.7% |
| 2024 | $1.37B | +19.1% |
| 2023 | $1.15B | -21.0% |
| 2022 | $1.46B | +4.0% |
| 2021 | $1.40B | -12.5% |
| 2020 | $1.60B | +190.0% |
| 2019 | $553.23M | -16.4% |
| 2018 | $661.98M | +36.0% |
| 2017 | $486.72M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $1.06B | -27.4% | -9.5% |
| June 30, 2025 | $1.17B | -22.4% | -8.3% |
| March 31, 2025 | $1.27B | -19.6% | -7.5% |
| December 31, 2024 | $1.37B | +19.1% | -5.5% |
| September 30, 2024 | $1.45B | +17.6% | -3.2% |
| June 30, 2024 | $1.50B | +15.1% | -5.0% |
| March 31, 2024 | $1.58B | +12.2% | +37.0% |
| December 31, 2023 | $1.15B | -21.0% | -6.7% |
- Denali Therapeutics Inc. showed a decrease of -16.7% in Total Assets compared to the prior fiscal year.
- Over the 2017–2025 period, Denali Therapeutics Inc.’s total assets has grown by 135.2% (from $486.72 million to $1.14 billion).
- The most recent figure is from Denali Therapeutics Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: